title: Stimulation of 2',5'-oligoadenylate synthetase activity in sheep endometrium during pregnancy, by intrauterine infusion of ovine trophoblast protein-1, and by intramuscular administration of recombinant bovine interferon-alpha I1.
abstract: In Expt 1, activity of 2',5'-oligoadenylate (2',5'-A) synthetase in endometrium collected on Day 16 (oestrus is Day 0) from the uterine horn ipsilateral to the corpus luteum was greater (P less than 0.001) for pregnant (135.5 +/- 1.72 nmol/mg protein/h) than for cyclic ewes (58.5 +/- 0.99 nmol/mg protein/h). In pregnant ewes, activity of 2',5'-A synthetase in endometrium collected from the contralateral uterine horn (119.5 +/- 1.72 nmol/mg protein/h) did not differ from that of the ipsilateral horn. In Expt 2, three ovariectomized ewes were treated with progesterone for 10 days and then with oestrogen for 2 days. Activity of 2',5'-A synthetase on Day 13 was 18% greater (P less than 0.10) in endometrium collected from the uterine horn receiving infusions of 30 micrograms ovine trophoblast protein-1 (oTP-1) twice a day on Days 10, 11 and 12(57.7 +/- 0.22 nmol/mg protein/h) than from the uterine horn receiving control infusions of serum protein (SP; 48.8 +/- 0.22 nmol/mg protein/h). In Expt 3, activity of 2',5'-A synthetase on Day 15 was not significantly greater in endometrium collected from the uterine horn of cyclic ewes receiving infusions of 30 micrograms oTP-1 twice a day on Days 12, 13 and 14 (46.5 +/- 0.37 nmol/mg protein/h) than in endometrium from the uterine horn receiving infusions of SP (38.2 +/- 0.37 nmol/mg protein/h). When results of Expt 2 and Expt 3 were combined, intrauterine infusion of oTP-1 increased (P less than 0.05) activity of 2',5'-A synthetase in endometrium by 20%.(ABSTRACT TRUNCATED AT 250 WORDS)
authors.affiliation: Animal Science Department, University of Florida, Gainesville 32611.
authors.forename: M A
authors.initials: MA
authors.lastname: Mirando
authors.forename: E C
authors.initials: EC
authors.lastname: Short
authors.forename: R D
authors.initials: RD
authors.lastname: Geisert
authors.forename: J L
authors.initials: JL
authors.lastname: Vallet
authors.forename: F W
authors.initials: FW
authors.lastname: Bazer
mesh_terms: D015088:2',5'-Oligoadenylate Synthetase / Q000378:metabolism*; D000818:Animals; D004717:Endometrium / Q000187:drug effects / Q000201:enzymology*; D005260:Female; D007273:Injections, Intramuscular; D007370:Interferon Type I / Q000008:administration & dosage*; D010052:Ovariectomy; D011247:Pregnancy; D011257:Pregnancy Proteins / Q000008:administration & dosage*; D011270:Pregnancy, Animal; D011994:Recombinant Proteins; D012756:Sheep / Q000378:metabolism*; D013268:Stimulation, Chemical
chemical_list: D007370:Interferon Type I; D011257:Pregnancy Proteins; D011994:Recombinant Proteins; C020947:interferon tau; D015088:2',5'-Oligoadenylate Synthetase